How Have Changes in Anemia Care Affected Patients with Kidney Failure?
American Society of Nephrology (ASN)2011 changes in policies and recommendations related to the use of erythropoietin-stimulating agents were associated with lower hemoglobin levels and lower risks of major adverse cardiovascular events, mortality, and stroke among adults receiving hemodialysis, but with a higher risk of heart attack.